Symbol="CARA"
AssetType="Common Stock"
Name="Cara Therapeutic"
Description="Cara Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing chemical entities with a primary focus on itching and pain by selectively targeting kappa opioid receptors in the United States. The company is headquartered in Stamford, Connecticut."
CIK="1346830"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="4 STAMFORD PLAZA, 107 ELM STREET 9TH FLOOR, STAMFORD, CT, US"
FiscalYearEnd="December"
LatestQuarter="2023-06-30"
MarketCapitalization="165728000"
EBITDA="-114902000"
PERatio="None"
PEGRatio="0"
BookValue="2.015"
DividendPerShare="0"
DividendYield="0"
EPS="-1.48"
RevenuePerShareTTM="0.505"
ProfitMargin="0"
OperatingMarginTTM="-4.237"
ReturnOnAssetsTTM="-0.399"
ReturnOnEquityTTM="-0.713"
RevenueTTM="27172000"
GrossProfitTTM="-56141000"
DilutedEPSTTM="-1.48"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="-0.699"
AnalystTargetPrice="16.93"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="15.22"
PriceToBookRatio="3.399"
EVToRevenue="12.05"
EVToEBITDA="-5.31"
Beta="0.854"
num_52WeekHigh="12.81"
num_52WeekLow="2.57"
num_50DayMovingAverage="3.08"
num_200DayMovingAverage="7.04"
SharesOutstanding="53983000"
DividendDate="None"
ExDividendDate="None"
symbol="CARA"
open="3.06"
high="3.06"
low="2.95"
price="3.00"
volume="475578.00"
latest_trading_day="2023-08-14"
previous_close="3.07"
change="-0.07"
change_percent="-2.2801%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="100"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Sell Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="0"
Volume_recent_avg="1104025"
Change_recent_avg="-0.03"
Delta_recent_avg="0.23"
Variance_recent_avg="0.11"
Change_ratio_recent_avg="-0.79"
RSI_change="FALSE"
ADX_change="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="0"
Aroon_momentum_negative="100"
image_negative_thumbnail_id_1="507"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0098.jpeg"
image_negative_thumbnail_id_2="1162"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0196.jpeg"
image_neutral_thumbnail_id_1="530"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0069.jpeg"
image_neutral_thumbnail_id_2="581"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0018.jpeg"
image_positive_thumbnail_id_1="982"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0144.jpeg"
image_positive_thumbnail_id_2="699"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0009.jpeg"
image_professor_thumbnail_id_1="1201"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0035.jpeg"
image_professor_thumbnail_id_2="1199"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0033.jpeg"
